New Study Reveals Risks of Common Sepsis Treatment
Examining the Impact of Anti-Anaerobic Antibiotics on Sepsis Outcomes
Topline:
A recent study highlights the potential dangers associated with using piperacillin-tazobactam in treating sepsis, revealing increased mortality and prolonged organ dysfunction compared to cefepime.
